Skip to main content
SpringerLink
Log in

Reply: “Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-years follow-up”

  • Letter to the Editor
  • Published:
Medical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ali N, Abbasi AN, Mansha MA. Correspondence on the article: “Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up”. Med Oncol. 2016;33(11):127.

    Article  PubMed  Google Scholar 

  2. Luvero D, Plotti F, Aloisi A, Capriglione S, Ricciardi R, Miranda A, Lopez S, Scaletta G, De Luca G, Benedetti-Panici P, Angioli R. Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-year follow-up. Med Oncol. 2016;33(10):110. doi:10.1007/s12032-016-0830-0.

    Article  PubMed  Google Scholar 

  3. Kidd EA, Siegel BA, Dehdashti F, Rader JS, Mutch DG, Powell MA, Grigsby PW. Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. J Clin Oncol. 2010;28(12):2108–13. doi:10.1200/JCO.2009.25.4151.

    Article  PubMed  Google Scholar 

  4. Angioli R, Plotti F, Montera R, Aloisi A, Luvero D, Capriglione S, Terranova C, De Cicco Nardone C, Muzii L, Benedetti-Panici P. Neoadjuvant chemotherapy plus radical surgery followed by chemotherapy in locally advanced cervical cancer. Gynecol Oncol. 2012;127(2):290–6. doi:10.1016/j.ygyno.2012.07.104.

    Article  CAS  PubMed  Google Scholar 

  5. Dueñas-González A, Zarbá JJ, Patel F, Alcedo JC, Beslija S, Casanova L, Pattaranutaporn P, Hameed S, Blair JM, Barraclough H, Orlando M. Phase III, open-label, randomized study comparing concurrent gemcitabine plus cisplatin and radiation followed by adjuvant gemcitabine and cisplatin versus concurrent cisplatin and radiation in patients with stage IIB to IVA carcinoma of the cervix. J Clin Oncol. 2011;29(13):1678–85. doi:10.1200/JCO.2009.25.9663.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, University of Rome “Campus Bio-Medico”, Via Alvaro del Portillo, 200, 00128, Rome, Italy

    D. Luvero, F. Plotti & R. Angioli

Authors
  1. D. Luvero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Plotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Angioli
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to D. Luvero.

Ethics declarations

Conflict of interest

Luvero Daniela, Plotti Francesco, and Angioli Roberto declare that they have no conflict of interest.

Ethical standards

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Luvero, D., Plotti, F. & Angioli, R. Reply: “Patients treated with neoadjuvant chemotherapy + radical surgery + adjuvant chemotherapy in locally advanced cervical cancer: long-term outcomes, survival and prognostic factors in a single-center 10-years follow-up”. Med Oncol 34, 14 (2017). https://doi.org/10.1007/s12032-016-0873-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-016-0873-2

Keywords

Search

Navigation